Know Labs Faces NYSE Delisting, Stock Moves to OTC Market

Know Labs, Inc. (KNWN) is taking steps to appeal its NYSE delisting. With its stock suspended from trading and currently valued at $0.072 on the OTC market, investors should watch for further developments that could impact the company's financial standing.

Date: 01-02-2025

AI Rating: 3

Delisting Challenges
Know Labs, Inc. (KNWN) is in a precarious situation as it faces delisting from the NYSE due to its stock bid price falling below $0.10. This is a signal of financial instability and lack of investor confidence. The company is appealing this decision and trying to regain compliance, indicating some effort toward restructuring.

Current Trading Status
While KNWN is suspended from trading on the NYSE American, it is currently trading at $0.072 on the over-the-counter (OTC) market, reflecting a 44% increase on the OTC Pink. However, the stock's low price level suggests significant risk and potential volatility for investors.

Effect on Investor Sentiment
The situation may lead to decreased confidence from current and potential investors, impacting stock prices further. Companies on the OTC market often have liquidity issues, less market visibility, and attract a different, often more speculative, investor base compared to those on major exchanges like the NYSE.

Stocks: KNWN